Search for: "In Re: Standard Jury Instructions in Criminal Cases - Report 2019-08" Results 1 - 2 of 2
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jan 2022, 7:16 am
  The case, In Re Valsartan, Losartan, and Irbesartan Products Liability Litigation (US DC NJ) MDL No. 2875 (RBK)is a products liability case that concerns the sale in the U.S. of generic, prescription Valsartan pharmaceuticals, found by the Food and Drug Administration [“FDA”] to contain cancer‐causing contaminants. [read post]